1. Home
  2. BCRX vs TSLX Comparison

BCRX vs TSLX Comparison

Compare BCRX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

SELL

Current Price

$7.63

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

SELL

Current Price

$17.53

Market Cap

1.8B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
BCRX
TSLX
Founded
1986
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
BCRX
TSLX
Price
$7.63
$17.53
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
★ $20.55
$19.77
AVG Volume (30 Days)
★ 5.1M
522.8K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
★ 9.94%
EPS Growth
★ 381.40
N/A
EPS
N/A
★ 0.51
Revenue
★ $25,186,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.71
$4.55
P/E Ratio
★ N/A
$34.92
Revenue Growth
N/A
★ N/A
52 Week Low
$6.23
$16.04
52 Week High
$11.22
$22.84

Technical Indicators

Market Signals
Indicator
BCRX
TSLX
Relative Strength Index (RSI) 49.24 54.36
Support Level $7.95 $17.14
Resistance Level $9.22 $17.94
Average True Range (ATR) 0.33 0.40
MACD 0.08 0.13
Stochastic Oscillator 53.73 66.38

Price Performance

Historical Comparison
BCRX
TSLX

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: